A
Absorption Rate Constant
Accumulation, Accumulation Ratio
Accuracy
Activity, Intrinsic
Addiction
Affinity
Agonist
Agonist, Partial
Agonist, Full
Agonist, Inverse
Allergic Response
Amplification
Analgesic
Anesthetic
Antagonism
Area Under the Curve
AUC
Availability
B
b
Bioassay or Biological Assay
Bioavailability
Biopharmaceutics
Biotransformation
Biotranslocation
Blind Experiment
C
Cl
Ceiling
Chemotherapy
Clearance
Clinical Therapeutic Index
Compartment(s)
Compliance
Cross-Over Experiment
Cross-Tolerance
CT Index
D*
D
Dependence
Desensitization
Disintegration Time
Dissolution Time
Distribution
Dosage Form
Dose
Dose-Duration Curve
Dose-Effect Curve
Drug
Drug Abuse
Drug Dependence
Dummy
EC
ED
Effective
Efficacy
Elimination Rate Constant
Equipotent
Equivalence
Experiment
f
F
First-Order Kinetics
First Pass Effect
Food and Drug Administration
Generic Drugs
Habituation
Half-Life
Harrison Act
Hazard
Hypersensitivity
Hypnotic
Idiosyncratic Response
Infusion Kinetics
Intrinsic Efficacy
k
Latent Period or Latency
Loading Dose
Maintenance Dose
Median Effective Dose
Metameter
Multiple Dose Regimens
N
Narcotic
National Formulary
Negative Control Drug or Negative Control Procedure
Parameter
Pharmacodynamics
Pharmacogenetics
Pharmacokinetics
Pharmacology
Placebo
Positive Control Drug
Potency
Potentiation
Priming Dose
Prodrug
Precision
R
Receptors
Reference Standard
Reliability
Risk
Selectivity
Sensitivity
Side Effects
Spare Receptors
Specificity
Standard Drug
Standardized Safety Margin
Supersensitivity
Synergy
T
Ï„
Tachyphylaxis
Therapeutic Index
Therapeutics
Threshold Dose
Time-Concentration Curve
Tolerance
Toxic Effects
Toxicology
Two-state Model
United States Pharmacopoeia
Validity
Volume of Distribution
Zero-Order Kinetics